Evaluating CVD Medication Adherence Program in Low SES

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

August 31, 2016

Conditions
Cardiovascular DiseaseHypertensionDiabetes
Interventions
BEHAVIORAL

m-health

Patients will receive e-reminders via text message and email. A message library that allows us to disseminate constant and reliable information has been created. Messages will contain not only medication reminders, but information about issues related to self-management and medication adherence for CVD risk including messages on side-effects, risks/benefits of medication treatment, and barriers to medication adherence. In addition to these messages, patients will also receive tailored information via telephone by trained research staff.

Trial Locations (1)

27705

Duke University Health System Clinic, Durham

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

PhRMA Foundation

UNKNOWN

lead

Duke University

OTHER